SEQ ID NO.1 of Patent CN114409737A

General Information


DRACP ID  DRACP06003

Peptide Name   SEQ ID NO.1 of Patent CN114409737A

Sequence  KLLKFIWRI

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Human epithelial cells: 97±7.1% Survival=100 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C62H101N15O10

Absent amino acids  ACDEGHMNPQSTVY

Common amino acids  IKL

Mass  135946

Pl  11.82

Basic residues  3

Acidic residues  0

Hydrophobic residues  6

Net charge  3

Boman Index  -103

Hydrophobicity  68.89

Aliphatic Index  173.33

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  687.5

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN114409737A

Patent Title  Novel anti-tumor peptide and application thereof

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.